SLC6A14 and breast carcinoma: Many cancers, particularly those of epithelial origin such as cervical [57], pancreatic ductal adenocarcinoma [58] and breast cancer [59] upregulate SLC6A14 to take advantage of its high capacity for glutamine uptake [52].